The health and safety of our patients, visitors and staff remains a top priority at Mater Private Network. With this in mind, we have revised our policy for visitors to the hospital, in line with the latest COVID-19 guidelines.

Learn More
3rd February 2022

Dublin Cardiovascular Research Forum - Prof Borja Ibáñez

Location: Online Time:  18:00 - 19:00 Open to: Professionals Credits: Applied for Contact: mary.ryan@materprivate.ie

Cardiovascular Research Institute Dublin at Mater Private Network is pleased to advise the Winter 2022 schedule for the Dublin Cardiovascular Research Forum.

 

For further information visit: www.cvridublin.ie/education-and-publication/dublin-cardiovascular-research-forum/future-events

 

Dublin Cardiovascular Research Forum is held via online webinar every Thursday from 6 – 7pm.

 

Speaker: Prof Borja Ibáñez, Director of Clinical Research of the National Center for Cardiovascular Research and interventional cardiologist at the University Hospital Fundación Jiménez Díaz, Spain.

Title: “Anthracycline-induced cardiotoxicity: mechanisms, early diagnosis and prevention”.

Prof Ibáñez was trained in Spain and in USA (Mount Sinai Heart, NY). His research is at the verge of basic and clinical arena, mainly in the fields of acute coronary syndrome, heart failure and lately to cancer therapy-induced cardiotoxicity. He is an advanced imaging user, and has used magnetic resonance imaging to better understand pathophysiology of myocardial diseases (tissue characterization) and to evaluate the benefits of cardioprotective therapies. He actively participates in primary prevention studies focused on atherosclerosis early identification by imaging to improve risk prediction. PI of several multicenter clinical trials recruiting patients with myocardial infarction and heart failure. He served as the Chairman of the 2017 European Society of Cardiology (ESC) STEMI Clinical Practice Guidelines. He is PI coordinator of several national and international projects, including H2020-funded grants, highlighting an active ERC consolidator grant and a H2020-HEALTH as coordinator devoted to the study of anthracycline-induced cardiotoxicity. He has published more than 300 scientific publications in high-impact journals. His H-index (scholar) is 64, and his works have received more than 30,000 citations (scholar). Inventor of several patents, some in the field of CMR. He is involved in peer review activities (funding agencies and scientific journals).

 

To receive a registration link please email Mary Ryan, Hospital Liaison Manager, Mater Private at mary.ryan@materprivate.ie or the CVRI Dublin team at cvri@materprivate.ie.